PEN Penumbra Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PEN

Price (delayed)

$227.75

Market cap

$8.79B

P/E Ratio

214.86

Dividend/share

N/A

EPS

$1.06

Enterprise value

$8.92B

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses ...

Highlights
The net income has increased by 39% from the previous quarter
PEN's EPS is up by 39% QoQ
Penumbra's debt has increased by 5% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.penumbrainc.com
Peers: PDEX OFIX NVRO

Key stats

What are the main financial stats of PEN
Market
Shares outstanding
38.6M
Market cap
$8.79B
Enterprise value
$8.92B
Valuations
Price to earnings (P/E)
214.86
Price to book (P/B)
7.93
Price to sales (P/S)
8.8
EV/EBIT
184.04
EV/EBITDA
118.73
EV/Sales
8.96
Earnings
Revenue
$995.06M
EBIT
$48.46M
EBITDA
$75.12M
Free cash flow
$47.28M
Per share
EPS
$1.06
Free cash flow per share
$1.23
Book value per share
$28.73
Revenue per share
$25.87
TBVPS
$31.95
Balance sheet
Total assets
$1.47B
Total liabilities
$364.24M
Debt
$228.79M
Equity
$1.1B
Working capital
$723.4M
Liquidity
Debt to equity
0.21
Current ratio
5.99
Quick ratio
3.14
Net debt/EBITDA
1.7
Margins
EBITDA margin
7.5%
Gross margin
63.7%
Net margin
4.1%
Operating margin
4.4%
Efficiency
Return on assets
2.9%
Return on equity
3.9%
Return on invested capital
4.2%
Return on capital employed
3.7%
Return on sales
4.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PEN stock price

How has the Penumbra stock price performed over time
Intraday
2.55%
1 week
-2.21%
1 month
17.36%
1 year
8.4%
YTD
2.38%
QTD
-5.85%

Financial performance

How have Penumbra's revenue and profit performed over time
Revenue
$995.06M
Gross profit
$634.08M
Operating income
$43.36M
Net income
$40.61M
Gross margin
63.7%
Net margin
4.1%
PEN's operating margin has soared by 194% YoY and by 13% from the previous quarter
The net income has increased by 39% from the previous quarter
Penumbra's net margin has increased by 32% QoQ
PEN's gross profit is up by 21% year-on-year and by 7% since the previous quarter

Growth

What is Penumbra's growth rate over time

Valuation

What is Penumbra stock price valuation
PEN P/E details
P/E
214.86
P/B
7.93
P/S
8.8
EV/EBIT
184.04
EV/EBITDA
118.73
EV/Sales
8.96
PEN's EPS is up by 39% QoQ
The stock's P/B is 26% below its 5-year quarterly average of 10.7 and 20% below its last 4 quarters average of 9.9
PEN's equity is up by 13% year-on-year and by 3.5% since the previous quarter
PEN's price to sales (P/S) is 23% lower than its 5-year quarterly average of 11.4 and 22% lower than its last 4 quarters average of 11.3
PEN's revenue is up by 20% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Penumbra business performance
PEN's ROS has soared by 194% YoY and by 20% QoQ
The ROA has grown by 38% from the previous quarter
The ROE has grown by 34% from the previous quarter
The company's return on invested capital rose by 24% QoQ

Dividends

What is PEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PEN.

Financial health

How did Penumbra financials performed over time
Penumbra's quick ratio has increased by 16% YoY and by 5% QoQ
Penumbra's current ratio has increased by 15% YoY and by 4.4% from the previous quarter
Penumbra's debt is 79% lower than its equity
PEN's equity is up by 13% year-on-year and by 3.5% since the previous quarter
PEN's debt to equity is down by 4.5% since the previous quarter and by 4.5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.